2022 annual financial data
Processa Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -20,257,288 USD and net income was -27,424,229 USD.
Operating cash flow was -9,605,143 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,257,288 USD
- Net income
- -27,424,229 USD
- Operating cash flow
- -9,605,143 USD